Santa Cruz Biotechnology offers a broad range of Bu-1a monoclonal antibodies for research applications. Bu-1a monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Bu-1a, a surface marker primarily expressed on B cells, plays a crucial role in the immune response by facilitating B cell activation and differentiation. Bu-1a expression patterns are significant indicators in studying B cell development and function throughout various stages of immune responses. Monitoring Bu-1a activity helps researchers understand cellular mechanisms involved in antibody production and immune regulation. Bu-1a research contributes to understanding B cell-related diseases and identifying potential therapeutic approaches. Investigating Bu-1a expression provides valuable information about B cell populations and their functional states. Bu-1a analysis enables deeper exploration of immune system dynamics and B cell responses. Santa Cruz Biotechnology monoclonal antibodies for Bu-1a research support scientists worldwide in advancing immunology research and developing new therapeutic strategies.